NIDC News

The DOE Isotope Program (DOE IP) is pleased to announce the availability of radium-224/lead-212 generators. Lead-212 (10.6 hour half-life) and its daughter bismuth-212 (60.6 minute half-life) are of interest in targeted alpha-particle therapy of cancer, including breast and ovarian cancers and melanoma. Research in progress is demonstrating the effectiveness of these isotopes in destroying cancer…

Join Us for the Isotope User Group Meetings   The U.S. Department of Energy Isotope Program will host three isotope-specific user group meetings during the upcoming SNMMI 2019 conference in Anaheim, CA. These 1-hour sessions offer a unique opportunity for isotope users to congregate and tackle pertinent issues through open discussion. Knowledgeable facilitators will guide…

Zirconium-89 is a radionuclide that’s just right for cancer tumor imaging. When the isotope is combined with a tumor-seeking molecule, it lasts long enough in the body to find the tumor and to be imaged. Researchers developed a less labor-intensive and more efficient way to chemically process and purify the isotope. They use a low energy cyclotron, a simple target station, and an automated…

The US Department of Energy Isotope Program (DOE IP) wants to hear from you at the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2018 Annual Meeting later this month in Philadelphia, PA. We invite you to join us at our DOE IP Users Meeting on Monday, June 25, from 7:00 a.m. to 8:00 a.m. An invitation to this open event from Dr. Jehanne Gillo, DOE IP Director, and Dr. Marc Garland,…

The US Department of Energy Isotope Program has agreed to terms with Bayer on a 10-year supply contract for actinium-227 (Ac-227) to support the company’s anticipated market growth of Xofigo®, a drug proven to prolong survival and improve the quality of life for patients with prostate cancer that has metastasized to the skeleton. The Ac-227 is produced at and shipped from Oak Ridge National…

The latest issue of our National Isotope Development Center (NIDC) Newsletter is now available! Read about the latest developments in the U.S. Department of Energy’s (DOE) isotope production, university partnerships, facility improvements, staff news, and other notable center activities. Highlights for this issue include:   DOE produces first newly enriched stable isotope in nearly two…

A team of 11 research staff at the Oak Ridge National Laboratory (ORNL) has been commended by the US Department of Energy (DOE) for their instrumental roles in the campaign to produce the enriched stable isotope ruthenium-96 (Ru-96), last produced in the United States more than 40 years ago. Presented on behalf of Dr. Stephen Binkley, Deputy Director for Science Programs in the Office of Science…

Suresh Srivastava, a Senior Medical Scientist Emeritus and research advisor in the Collider-Accelerator Department and Medical Isotope Research & Production Program at Brookhaven National Laboratory (BNL), is this year’s recipient of the Glenn T. Seaborg Award. He recently accepted the award during the American Chemical Society’s (ACS) Spring 2018 National Meeting & Exposition in New…

Subject to the availability of funds, the U.S. Department of Energy Isotope Program (DOE IP) considers a limited number of proposals to offer travel bursaries for students and postdoctoral trainees to attend domestic and international conferences, meetings, or workshops. All proposals are competitively reviewed, and selections are made based on numerous criteria that align with the DOE IP mission…

The DOE Isotope Program (DOE IP) will host three user group meetings during the upcoming Annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Philadelphia, PA. These meetings are being organized by the DOE IP to encourage free discussion and collaboration by users of specific isotopes as well as to provide information on the broader DOE IP portfolio. Details on each…